Patents by Inventor Joel Plumas

Joel Plumas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED PDC LINE FOR SECRETING A CYTOKINE
    Publication number: 20210393688
    Abstract: The present invention relates to a genetically modified PDC (plasmacytoid dendritic cell) line for secreting a cytokine and to its use for increasing the expansion of antigen-specific cells in immunotherapies.
    Type: Application
    Filed: October 23, 2019
    Publication date: December 23, 2021
    Inventors: Dalil HANNANI, Joel PLUMAS
  • Plasmacytoid dendritic cell line used in active or adoptive cell therapy
    Patent number: 9783782
    Abstract: The present invention relates to a method for inducing and amplifying specific effectors, which comprises obtaining pulsed plasmacytoid dendritic cells (pDC) by incubation of a pDC line with at least one antigen, the pulsed pDC being subsequently irradiated and brought into contact with peripheral blood mononuclear cells (PBMC), and cultured or injected into an organism. The pulsed and irradiated pDC and the PBMC share at least one major histocompatibility complex (MHC) allele.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: October 10, 2017
    Assignee: ETABLISSEMENT FRANCAIS DU SANG
    Inventors: Joel Plumas, Caroline Aspord, Laurence Chaperot-Dubonnet
  • PLASMACYTOID DENDRITIC CELL LINE USED IN ACTIVE OR ADOPTIVE CELL THERAPY
    Publication number: 20120020998
    Abstract: The present invention relates to a method for inducing and amplifying specific effectors, which comprises obtaining pulsed plasmacytoid dendritic cells (pDC) by incubation of a pDC line with at least one antigen, the pulsed pDC being subsequently irradiated and brought into contact with peripheral blood mononuclear cells (PBMC), and cultured or injected into an organism. The pulsed and irradiated pDC and the PBMC share at least one major histocompatibility complex (MHC) allele.
    Type: Application
    Filed: May 15, 2009
    Publication date: January 26, 2012
    Applicant: ETABLISSEMENT FRANCAIS DU SANG
    Inventors: Joel Plumas, Caroline Aspord, Laurence Chaperot-Dubonnet
  • Dendritic cell line
    Patent number: 7341870
    Abstract: The invention relates to plasmacytoid dendritic human cell lines and methods for producing the cell lines. More specifically, the invention relates to the plasmacytoid dendritic human cell line called GEN2.2, which is deposited in the CNCM under number CNCM 1-2938 and the plasmacytoid dendritic human cell line called GEN3, which is deposited in the CNCM under number I-3110. The use of cells from the cell lines is also disclosed.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: March 11, 2008
    Assignee: Etablissement Francais du Sang
    Inventors: Joel Plumas, Laurence Chaperot-Dubonnet
  • Dendritic cell line
    Publication number: 20050272151
    Abstract: The invention relates to plasmacytoid dendritic human cell lines (pDC), methods for the production thereof and to said cells. More specifically, said invention relates to the plasmacytoid dendritic human cell line called GEN2.2 which is deposited in CNCM under number CNCM I-2938. The use of said cells and pharmaceutical compounds containing plasmacytoid dendritic human cells (pDC) are also disclosed.
    Type: Application
    Filed: December 16, 2003
    Publication date: December 8, 2005
    Applicant: ETABLISSEMENT FRANCAIS DU SANG
    Inventors: Joel Plumas, Lawrence Chaperot-Dubonnet